PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 28 filers reported holding PROTEON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $63,000 | +57.5% | 155,689 | 0.0% | 0.00% | – |
| Q3 2019 | $40,000 | -37.5% | 155,689 | 0.0% | 0.00% | – |
| Q2 2019 | $64,000 | +300.0% | 155,689 | +381.4% | 0.00% | – |
| Q1 2019 | $16,000 | -89.0% | 32,340 | -50.0% | 0.00% | – |
| Q4 2018 | $146,000 | +131.7% | 64,680 | +100.0% | 0.00% | – |
| Q3 2018 | $63,000 | -20.3% | 32,340 | 0.0% | 0.00% | – |
| Q2 2018 | $79,000 | -1.2% | 32,340 | 0.0% | 0.00% | – |
| Q1 2018 | $80,000 | +31.1% | 32,340 | 0.0% | 0.00% | – |
| Q4 2017 | $61,000 | -11.6% | 32,340 | -6.6% | 0.00% | – |
| Q3 2017 | $69,000 | +30.2% | 34,613 | 0.0% | 0.00% | – |
| Q2 2017 | $53,000 | -19.7% | 34,613 | -9.0% | 0.00% | – |
| Q1 2017 | $66,000 | -7.0% | 38,031 | +1.2% | 0.00% | – |
| Q4 2016 | $71,000 | -79.5% | 37,569 | +0.8% | 0.00% | – |
| Q3 2016 | $347,000 | +16.4% | 37,261 | +0.2% | 0.00% | – |
| Q2 2016 | $298,000 | -15.1% | 37,184 | -18.1% | 0.00% | – |
| Q1 2016 | $351,000 | -47.0% | 45,412 | +6.3% | 0.00% | – |
| Q4 2015 | $662,000 | +14.3% | 42,727 | +2.5% | 0.00% | – |
| Q3 2015 | $579,000 | -19.9% | 41,690 | +3.0% | 0.00% | – |
| Q2 2015 | $723,000 | +171.8% | 40,482 | +76.8% | 0.00% | – |
| Q1 2015 | $266,000 | +133.3% | 22,891 | +108.3% | 0.00% | – |
| Q4 2014 | $114,000 | – | 10,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|